Search Within

Marc Ladanyi

  1. "Camelia Sima"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (11)
Groups
  1. Department of Medicine (32)
  2. Department of Pathology and Laboratory Medicine (32)
  3. GSK Faculty (32)
  4. Human Oncology and Pathogenesis Program (32)
  5. Solid Tumor Oncology Division (32)
  6. Thoracic Oncology (32)

More Groups

People
  1. Camelia Sima (32)
  2. Mark Kris (28)
  3. Gregory Riely (22)
  4. Maria Arcila (10)
  5. Paul Paik (10)
  6. Helena Yu (8)

More People

Years
  1. 2016 (2)
  2. 2015 (4)
  3. 2014 (3)
  4. 2013 (10)
  5. 2012 (7)
  6. 2011 (5)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Thoracic Oncology (10)
  3. Cancer (3)
  4. Clinical Cancer Research (3)
  5. Molecular Cancer Therapeutics (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (10)
  2. Elsevier Inc. (10)
  3. American Association for Cancer Research (6)
  4. Wiley Blackwell (3)
  5. European Respiratory Society (1)
  6. Nature Research (1)

More Publishers

Results (32)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Next-generation sequencing of stage IV squamous cell lung cancers reveals an association of PI3K aberrations and evidence of clonal heterogeneity in patients with brain metastases
    Journal Article

    Paik, P. K.; Shen, R.; Won, H.; Rekhtman, N.; Wang, L.; Sima, C. S.; Arora, A.; Seshan, V.; Ladanyi, M.; Berger, M. F.; more...
    Cancer Discovery (2016)

    Fulltext@MSK | Save
  • Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers
    Journal Article

    Drilon, A.; Bergagnini, I.; Delasos, L.; Sabari, J.; Woo, K. M.; Plodkowski, A.; Wang, L.; Hellmann, M. D.; Joubert, P.; Sima, C. S.; more...
    Annals of Oncology (2016)

    Fulltext@MSK | Save
  • Impact of concurrent PIK3CA mutations on response to EGFR tyrosine kinase inhibition in EGFR-mutant lung cancers and on prognosis in oncogene-driven lung adenocarcinomas
    Journal Article

    Eng, J.; Woo, K. M.; Sima, C. S.; Plodkowski, A.; Hellmann, M. D.; Chaft, J. E.; Kris, M. G.; Arcila, M. E.; Ladanyi, M.; Drilon, A.
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Epidermal growth factor receptor exon 20 insertions in advanced lung adenocarcinomas: Clinical outcomes and response to erlotinib
    Journal Article

    Naidoo, J.; Sima, C. S.; Rodriguez, K.; Busby, N.; Nafa, K.; Ladanyi, M.; Riely, G. J.; Kris, M. G.; Arcila, M. E.; Yu, H. A.
    Cancer (2015)

    Fulltext@MSK | Save
  • Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers
    Meeting Abstract

    Drilon, A. E.; Sima, C. S.; Somwar, R.; Smith, R.; Ginsberg, M. S.; Riely, G. J.; Rudin, C. M.; Ladanyi, M.; Kris, M. G.; Rizvi, N. A.
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prognostic impact of KRAS mutation subtypes in 677 patients with metastatic lung adenocarcinomas
    Journal Article

    Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S.; Gainor, J.; Shaw, A.; Hames, M.; Iams, W.; Aston, J.; Lovly, C. M.; more...
    Journal of Thoracic Oncology (2015)

    Fulltext@MSK | Save
  • Concurrent molecular alterations in KRAS-mutant lung adenocarcinomas and effects on overall survival
    Meeting Abstract

    Riely, G. J.; Eng, J.; Yu, H. A.; Hsu, M.; Kris, M. G.; Borsu, L.; Cavatore, M.; Yannes, A.; Brzostowski, E.; Casanova, J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Alterations in two oncogenic drivers: Impact of concurrent PIK3CA or AKT1 mutations in patients with oncogene-driven lung adenocarcinomas
    Meeting Abstract

    Eng, J.; Hellmann, M. D.; Woo, K.; Sima, C. S.; Yu, H. A.; Arcila, M. E.; Ladanyi, M.; Kris, M. G.; Drilon, A. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical characteristics and course of 63 patients with BRAF mutant lung cancers
    Journal Article

    Litvak, A. M.; Paik, P. K.; Woo, K. M.; Sima, C. S.; Hellmann, M. D.; Arcila, M. E.; Ladanyi, M.; Rudin, C. M.; Kris, M. G.; Riely, G. J.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Comparison of the characteristics and clinical course of 677 patients with metastatic lung cancers with mutations in KRAS codons 12 and 13
    Meeting Abstract

    Yu, H. A.; Sima, C. S.; Shen, R. L.; Kass, S. L.; Kris, M. G.; Ladanyi, M.; Riely, G. J.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save